MacroGenics, Inc. (MGNX)
3.52
+0.03
(+0.86%)
USD |
NASDAQ |
Apr 15, 16:00
3.50
-0.02
(-0.57%)
After-Hours: 20:00
MacroGenics Research and Development Expense (Annual) : 140.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 6.974B |
| Amicus Therapeutics, Inc. | 135.84M |
| Merck & Co., Inc. | 12.51B |
| Pfizer Inc. | 10.25B |
| Xencor, Inc. | 239.43M |